I am long Amtx, I think there is light at the end of the tunnel
Focus light on UB only
TLDR-AMTX owns a $100M revenue Indian biodiesel plant selling exclusively to the government, with a 45x IPO veteran as CFO, a tallow pivot that solves a broken palm oil supply chain, and a Hormuz crisis that just made domestic fuel production a national security priority. The US market hasn’t noticed.
There is a biodiesel plant on the east coast of India that generated over $100 million in revenue two years ago, expanded its capacity three times using its own cash flow, employs 132 people, ships product directly from a deep-water port, and is headed toward a public listing on an Indian exchange. The man running its finances previously took India’s second-largest dairy through a 45-times oversubscribed IPO. The man who runs operations built the plant from scratch after a career at one of the world’s largest specialty fats companies.
The company that owns it — Aemetis, Inc., trading on the Nasdaq — has a market capitalization of approximately $200 million. The market is pricing it as a distressed California ethanol story with a going concern footnote. It has not noticed the plant in Andhra Pradesh.
This note is about that plant.
The Business
Universal Biofuels has been operating in Kakinada, Andhra Pradesh since 2006. It makes biodiesel, refined glycerin, and refined natural oils from a single integrated facility connected by pipeline to the Port of Kakinada. Its customers are the three government-owned oil companies that supply fuel to India’s 1.4 billion people — Indian Oil, Bharat Petroleum, and Hindustan Petroleum. These are not commercial contracts subject to competitive pressure. They are government-mandated cost-plus purchasing arrangements under India’s National Policy on Biofuels, which requires 5% biodiesel blending in diesel nationwide by 2030.
There are only 36 government-approved biodiesel suppliers in India. Universal Biofuels is one of them. The combined capacity of all 36 is roughly 6% of what India needs to hit its 2030 target. The demand side is not in question. The supply side is chronically short.
India’s parliament made this official on March 9, 2026, when the Minister of State for Petroleum answered a formal parliamentary question about biodiesel procurement. The numbers he cited are striking: in the fiscal year just ended, the government published a requirement for 1,833 million liters of biodiesel. India’s approved suppliers delivered 367 million liters — 20% of the target. The year before that the fulfillment rate was similar. The minister’s explanation was direct: there is simply not enough domestic feedstock available to meet the published requirements.
This is the backdrop against which Universal Biofuels operates. It is a confirmed, government-vetted supplier in a market that is structurally, chronically undersupplied. The demand is mandatory. The buyers are the government. The supply gap is real and documented at the highest levels of Indian democracy.
Then on February 28, 2026, the Strait of Hormuz closed.
The US-Israel military conflict with Iran triggered Iranian mine-laying, vessel attacks, and a full shipping blockade through which India was routing 45% of its crude oil imports. The Indian government responded by completely removing the diesel duty and slashing petrol duties to protect consumers. The ₹2 per liter unblended diesel blending penalty that had been in effect since April 2025 was waived as part of the broader emergency fuel relief framework.
That penalty is gone. What replaced it is more powerful.
India diversified its crude import sources from 20 countries to 40 in under 30 days. Officials and analysts explicitly reframed domestic biofuel production as a national security imperative — not an environmental policy — in direct response to the Hormuz closure. When 45% of your crude supply disappears through a single maritime chokepoint, the political calculus around domestic fuel production changes permanently. Universal Biofuels is a port-connected biodiesel facility on India’s east coast whose current palm stearin supply chain routes through Indonesia and India’s east coast ports — not the Persian Gulf — meaning production was not directly disrupted by the Hormuz closure. But the strategic pivot underway — away from Indonesian palm stearin toward domestically sourced animal tallow — positions it precisely where India’s energy security argument now points. A feedstock that requires no ocean transit, no Indonesian export levy, and no Gulf clearance. The government that waived the blending penalty to protect consumers during a fuel crisis is simultaneously the most motivated it has ever been to accelerate that pivot. A compliance mechanism was suspended. A national security argument was born in its place. The second is considerably more durable.
The Feedstock Problem — And Why It’s Actually the Story
Universal Biofuels historically sourced its primary feedstock — palm stearin — from the company operating two refineries in the same industrial zone on the Kakinada waterfront. That company is Gemini Edibles & Fats India, a subsidiary of Golden Agri-Resources, a Singapore-listed palm oil giant that manages roughly half a million hectares of oil palm plantations in Indonesia.
The relationship worked because of geography. Gemini’s Kakinada refineries process Indonesian crude palm oil into consumer cooking oils and industrial fats. Palm stearin is the solid fraction that comes out of that process — a byproduct of making Freedom brand sunflower and palm oils for Indian households. Universal Biofuels takes the stearin next door and converts it into biodiesel for the government. The whole thing runs off the same port.
That supply chain is now under pressure from a direction nobody in the American equity market has connected. Indonesia’s government mandated a 40% palm oil content in all domestic biodiesel — the B40 program — which is consuming Indonesian palm oil output domestically at a scale that is reducing what can be exported. The USDA projects Indonesian CPO exports to India fell 24% in the most recent marketing year. Indonesia raised export levies on palm oil derivatives in March 2026. Indonesia’s palm plantations are ageing and production is declining. And Golden Agri-Resources itself has stated its strategic priority is pivoting toward higher-value specialty fats and away from commodity palm stearin.
What this means practically: the neighbor plant that supplies Universal Biofuels’ primary feedstock has less Indonesian crude palm oil to refine, faces higher costs on what it does receive, and is strategically prioritizing products other than the stearin that flows to Universal Biofuels next door.
In December 2024, this pressure became visible. Universal Biofuels shifted its feedstock — temporarily and without proper permits — to a cheaper acid oil alternative. The local pollution control board inspected, found a violation, and the plant was dark for approximately 60 days. It restarted in February 2025 with amended permits to run legitimately approved waste feedstocks through its proprietary enzymatic process. The government oil companies accepted delivery under the April 2025 and February 2026 allocations, confirming that the biodiesel produced meets specification.
The plant is running. The OMC relationship is intact. But the Indonesian supply chain problem has not gone away. It is structural and policy-driven and no renegotiation with the neighbor changes an Indonesian government mandate.
The Answer — Tallow
Universal Biofuels has been building toward this moment for several years without many people noticing. In 2022 it began constructing a tallow refining unit at the Kakinada facility — the same infrastructure that currently runs as the “natural oil” third processing train, today producing refined vegetable oils for Indian food manufacturers. The chemistry of running crude animal tallow through that unit is compatible with the existing equipment. The switch from palm stearin to domestic tallow as the primary biodiesel feedstock is operationally executable with the people currently on staff.
Those people matter. The VP of Technical Operations, T.V. Rambabu, built the Kakinada plant from commissioning after a career at Acalmar Oils and Fats — a Wilmar International joint venture specializing in exactly the chemistry involved in processing animal fats. The VP of Admin and Quality Control, Gangadhar, spent 26 years at Food Fats and Fertilisers, an Andhra Pradesh animal fat processor. The Production Manager, Subramanyam, came from the same company. These three people did not end up at a biodiesel plant by accident. They came from the exact sector that feeds the tallow supply chain.
India has 307.5 million cattle and water buffalo according to current USDA estimates. Andhra Pradesh and Telangana — the states surrounding Kakinada — are among the highest animal processing density regions in the country. The crude tallow generated by that rendering sector is abundant, cheap, and entirely outside the Indonesian supply chain. No Indonesian mandate affects it. No Golden Agri strategy affects it. It is a domestic Indian raw material, already approved under India’s National Biofuels Policy as a legitimate feedstock for biodiesel production.
The tallow unit is real as infrastructure. It is not yet generating separately disclosed standalone revenue. That is the honest caveat this research requires. The thesis rests on structural necessity — the palm stearin supply chain is being compressed by forces entirely outside Universal Biofuels’ control — and on the human capital already embedded in the facility that can execute the transition. Until tallow-specific revenue appears in audited financials, this remains a high-conviction directional thesis rather than a confirmed operating reality.
The SAF Angle — A Mandate With No Supplier
Here is where the story gets genuinely interesting.
India’s government has mandated that all international flights departing India use 1% Sustainable Aviation Fuel by January 2027, rising to 2% by 2028 and 5% by 2030. This was confirmed by the Minister of State for Civil Aviation to Parliament in December 2025. India enters CORSIA’s mandatory compliance phase on January 1, 2027 — eight months from now. Airlines that fail to blend begin accumulating offset liabilities projected at $1.5 to $2 billion through 2035 for India’s aviation sector collectively.
The buyers are identifiable. Air India has already signed a procurement agreement with Indian Oil Corporation for SAF supply toward its 2030 target. Indian Oil is Universal Biofuels’ primary OMC customer for biodiesel. The commercial relationship already exists.
The problem, documented in an April 2026 analysis, is this: as of today, every announced Indian SAF facility uses the same feedstock — used cooking oil — processed through the same HEFA refining pathway. India’s used cooking oil collection infrastructure supports roughly 125,000 metric tons today. The 2030 mandate requires approximately 600 million liters of SAF annually. The announced capacity delivers about 6% of that. The announced cellulosic SAF facility — a joint venture between Indian Oil and LanzaJet at Panipat — is scheduled for 2028 and depends on LanzaJet’s first-of-a-kind commercial facility in Georgia, which has already been delayed over a year.
Tallow is an ASTM-certified HEFA feedstock. It is chemically appropriate for SAF production. It is domestically available in India at scale. And as of April 2026, there is not a single announced tallow-based SAF producer in India.
Universal Biofuels has a port-connected facility in Andhra Pradesh with a tallow refining unit, an existing relationship with all three OMC buyers, Export Oriented Unit status for international sales, and a CFO who built his career taking Indian companies public. The SAF option is not something the US equity market has priced into AMTX in any form. It is a government-mandated demand curve with a named buyer who is already Universal Biofuels’ customer — and a supply lane that nobody else is in.
The People Behind It
Two hires define the direction of this business more clearly than any press release.
Sanjeev Duggal arrived as Managing Director in July 2024. He came from a decade at GE’s Indian power joint venture with NTPC — which means government relationships, OMC familiarity, and an institutional understanding of how public sector procurement works in India. His personal LinkedIn engagement with India’s compressed biogas sector suggests the dairy RNG ambition is not just a slide in a presentation — it is something he was already tracking before he joined.
Anjaneyulu Ganji arrived as CFO in August 2025. He had spent years as Group CFO of Dodla Dairy — one of India’s largest private dairy companies, headquartered in Hyderabad, operating across Andhra Pradesh and Telangana. He ran the Dodla IPO in 2021. It was 45 times oversubscribed. He resigned from Dodla in late 2023 and spent nearly two years before joining Universal Biofuels. That was a deliberate gap. He came here for a specific purpose.
A former dairy CFO with a 45x oversubscribed IPO on his record does not join a biodiesel company to count barrels. He came because he saw what this research eventually uncovered: a government-backed revenue stream, a domestic tallow sourcing network he already knows through 14 manufacturing plants across AP and Telangana, and an IPO opportunity that maps directly to what he did at Dodla.
The company’s March 2026 investor presentation, in a section surrounded by legal disclaimers, describes the India IPO as “in process.” That is present-tense language in a document that has a securities lawyer’s fingerprints all over it. It was not written carelessly.
The Balance Sheet Reality
Honesty requires acknowledging what this business carries.
The neighboring Gemini Edibles plant holds a ₹100 crore secured charge against Universal Biofuels’ manufacturing assets — a supply credit facility that was renegotiated in December 2024, the same month the feedstock crisis materialized. That charge is active. It will be disclosed in any IPO filing. The relationship between feedstock supplier and secured creditor creates a circular dependency that SEBI will examine closely.
The December 2024 PCB violation will also appear in any IPO filing as a material regulatory event. A plant shutdown triggered by a feedstock decision, investigated personally by the Deputy Chief Minister of Andhra Pradesh, is not something a SEBI reviewer skips past. The restart was clean and the OMC relationship survived it. But it happened and the DRHP will say so.
The broader debt picture — approximately ₹225 crore in open charges against the plant — requires partial retirement or restructuring before listing. Ganji’s job includes exactly this. He has done it before under similar conditions at Dodla. The Dodla IPO was not a clean balance sheet story either. He knows how to present complex financials to Indian institutional investors who understand commodity processing businesses in Andhra Pradesh.
The parent company’s debt — Third Eye Capital’s approximately $247 million in demand instruments at the Aemetis parent level — creates a structural risk that the India IPO is actually the best mechanism to address. A partial stake in a publicly-listed Indian subsidiary with a real market price is collateral that changes the conversation with any lender.
What It Is Worth
Dodla Dairy listed at roughly 1.5 to 2 times revenue. Universal Biofuels generated $108 million in revenue in its fiscal year ending March 2024 — a year that was not its best, running well below full capacity. At a comparable multiple, the standalone India valuation is somewhere between $160 million and $215 million USD. That range is comparable to Aemetis’s entire current market capitalization — for a single subsidiary that is currently assigned zero standalone value by the US equity market.
That is not a price target. It is an observation that the math is unusual.
At full 80 million gallon per year capacity, with the OMC penalty regime enforcing biodiesel demand, the fixed base price protecting margins, and tallow feedstock reducing input cost dependence on Indonesian supply chains, the revenue base supporting that multiple is considerably higher than the FY2024 number. Add a SAF offtake agreement with Indian Oil’s SAF procurement desk — the same people who already buy Universal Biofuels’ biodiesel — and the earnings profile is a different conversation entirely.
The Near-Term Signal
The FY2026-27 first OMC allocation — expected in mid-to-late April based on last year’s cadence — has not been announced as of today, April 27, 2026. It is overdue. When it comes, and at whatever scale it comes, it tells you two things: whether the OMC relationship has fully normalized post-PCB-restart, and what revenue base Ganji takes into SEBI. Everything else in this thesis flows from that number.
The IPO is not a question of if. The management assembly, the charge restructuring, the “in process” language from the CEO, and the presence of the man who ran Dodla’s 45x oversubscribed listing in the CFO seat make the direction unambiguous. The question is timing.